| OHA | Oral Hypoglycemic Agents |
|---|---|
| CTA | Canadian Tuberculosis Association; chemotactic activity; chromotropic acid; Committee on Thrombolyti... |
| ICAAC | Interscience Conference on Antimicrobial Agents and Chemotherapy |
| NAHPA | National Association of Hospital Purchasing Agents |
| OHA | oral hypoglycemic agents |
| BRM | Biologic response modifiers |
|---|---|
| CWA | Chemical warfare agents |
| DBA | Dentin bonding agents |
| NSAID | non steroidal anti-inflammatory agents |
| NSAIA | Non-steroidal anti-inflammatory agents |
| biologic | Pertaining to biology. (18 Nov 1997) |
|---|---|
| biologic evolution | Biologic evolution was contrasted with cultural evolution in 1968 by A.G. Motulsky who pointed out that biologic evolution is mediated by genes, shows a slow rate of change, employs random variation (mutations) and selection as agents of change, new variants are often harmful, these new variants are transmitted from parents to offspring, the mode of transmission is simple, complexity is achieved by the rare formation of new genes by chromosome duplication, biologic evolution occurs with all forms of life, and the biology of humans requires cultural evolution. See Cultural evolution. (12 Dec 1998) |
| biologic haemolysis | Haemolysis caused by agents elaborated by various animal and plant forms. (05 Mar 2000) |
| biologic time | The concept that our appreciation of time varies with age and is governed by the neural organization of the individual; it obeys a logarithmic rather than an arithmetic law. (05 Mar 2000) |
| evolution, biologic | A.G. Motulsky in 1968 contrasted biologic evolution with cultural evolution, pointing out that biologic evolution is mediated by genes, shows a slow rate of change, employs random variation (mutations) and selection as agents of change, new variants are often harmful, these new variants are transmitted from parents to offspring, the mode of transmission is simple, complexity is achieved by the rare formation of new genes by chromosome duplication, biologic evolution occurs with all forms of life, and the biology of humans requires cultural evolution. See Evolution, cultural. (12 Dec 1998) |
| abortifacient agents | Chemical substances that interrupt pregnancy after implantation. (12 Dec 1998) |
| abortifacient agents, non-steroidal | Non-steroidal chemical compounds with abortifacient activity. (12 Dec 1998) |
| abortifacient agents, steroidal | Steroidal compounds with abortifacient activity. (12 Dec 1998) |
| adrenergic agents | Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (12 Dec 1998) |
| alkylating agents | Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agent, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (12 Dec 1998) |
| anti-allergic agents | Agents that are used to treat allergic reactions. most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (12 Dec 1998) |
| anti-allergic and respiratory system agents | A collective term for drugs used to treat allergic reactions as well as those drugs that produce an effect on the respiratory system. (12 Dec 1998) |
| anti-anxiety agents | Agents that alleviate anxiety, tension, and neurotic symptoms, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anaesthesia adjuvants. Adrenergic beta-antagonists are commonly used in the symptomatic treatment of anxiety but are not included here. Substances with a benzodiazepine ring structure widely used to treat anxiety and neuroses. Drugs in this class also generally have sedative or weak hypnotic properties and may be effective as muscle relaxants, anticonvulsants, and anaesthesia adjuvants. (12 Dec 1998) |
| anti-arrhythmia agents | Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (12 Dec 1998) |
| anti-asthmatic agents | Drugs that are used to treat asthma. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|